Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
KraneShares Bosera MSCI China A ETF | KBA | Mar 14, 2025 | 24.73 | +3.45 |
Kraneshares Csi China Internet | KWEB | Mar 14, 2025 | 36.78 | +2.97 |
Kratos Defense & Security Solutions | KTOS | Mar 14, 2025 | 30.43 | +3.08 |
Krispy Kreme | DNUT | Mar 14, 2025 | 5.36 | +0.19 |
Kroger | KR | Mar 14, 2025 | 65.10 | -1.51 |
Kronos Bio | KRON | Mar 14, 2025 | 0.94 | +2.65 |
Kronos Worldwide | KRO | Mar 14, 2025 | 7.85 | +2.75 |
Krystal Biotech | KRYS | Mar 14, 2025 | 179.38 | +1.13 |
KT ADR | KT | Mar 14, 2025 | 18.28 | +1.11 |
Kuke Music ADR | KUKE | Mar 14, 2025 | 2.10 | +5.00 |
Kulicke and Soffa Industries | KLIC | Mar 14, 2025 | 36.74 | +3.23 |
KULR Technology Group | KULR | Mar 14, 2025 | 1.45 | +14.17 |
Kura Oncology | KURA | Mar 14, 2025 | 7.14 | -1.92 |
Kura Sushi USA A | KRUS | Mar 14, 2025 | 50.55 | +1.18 |
KVH Industries | KVHI | Mar 14, 2025 | 5.29 | +2.92 |
KWESST Micro Systems | KWE | Mar 14, 2025 | 0.36 | -0.39 |
Kymera Therapeutics | KYMR | Mar 14, 2025 | 34.37 | +2.75 |
Kyndryl | KD | Mar 14, 2025 | 35.27 | +4.50 |
Kyverna Therapeutics | KYTX | Mar 14, 2025 | 2.50 | 0.00 |
L.B. Foster | FSTR | Mar 14, 2025 | 20.31 | +2.06 |
L3Harris Technologies | LHX | Mar 14, 2025 | 211.06 | -0.06 |
La Rosa Company | LRHC | Mar 14, 2025 | 0.22 | +7.22 |
La-Z-Boy | LZB | Mar 14, 2025 | 38.37 | +0.10 |
Labcorp | LH | Mar 14, 2025 | 239.53 | +1.65 |
Ladder Capital | LADR | Mar 14, 2025 | 11.66 | +2.28 |
Laird Superfood | LSF | Mar 14, 2025 | 5.34 | +13.38 |
Lake Shore Bancorp | LSBK | Mar 14, 2025 | 15.98 | -1.65 |
Lakeland Financial | LKFN | Mar 14, 2025 | 62.33 | +1.81 |
Lakeland Industries | LAKE | Mar 14, 2025 | 20.10 | +0.95 |
LakeShore Biopharma | LSB | Mar 14, 2025 | 2.00 | +5.26 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.